SPONSOR
Maastricht University Medical Center
Total Trials
8
Recruiting
8
Phases
Phase 2
Conditions studied: Inflammatory Bowel Disease (IBD)Ulcerative Colitis (UC)Crohn Disease (CD)Pre-EclampsiaHELLP SyndromeIntrauterine Growth RestrictionPregnancyNon-Small Cell Lung CancerPrehabilitationPancreas Cancer
Maastricht University Medical Center is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn Disease (CD), Pre-Eclampsia.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Maastricht University Medical Center
How many clinical trials has Maastricht University Medical Center sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by Maastricht University Medical Center, of which 8 are actively recruiting participants. These trials cover conditions including Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn Disease (CD). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Maastricht University Medical Center research focus on?
Maastricht University Medical Center clinical trials span Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn Disease (CD), Pre-Eclampsia, HELLP Syndrome, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Maastricht University Medical Center clinical trial?
To participate in a Maastricht University Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Maastricht University Medical Center trials with current recruitment status updated daily.
Clinical Trials by Maastricht University Medical Center
NCT07647640
Recruiting
Prospective Evaluation of Flare Detection in IBD With Digital Biomarkers: Bring Your Own Device Study
Inflammatory Bowel Disease (IBD)
NCT05500989
Recruiting
PlacEntal Acute Atherosis RefLecting Subclinical Atherosclerosis
Pre-Eclampsia
NCT07485452 Phase 2
Recruiting
Boosting Osimertinib Blood Brain Barrier Penetration
Non-Small Cell Lung Cancer
NCT05851534
Recruiting
Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas
Prehabilitation
NCT06923644
Recruiting
Targeted Precision Nutrition Strategy To Prevent Chronic Metabolic Diseases
Obesity and Overweight
NCT07501780
Recruiting
Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice
Basal Cell Carcinoma of Skin
NCT02650453
Recruiting
Ongoing Registry of Deep Venous Reconstructions
Venous Thrombosis
NCT05655780
Recruiting
The Role of the Tumor Molecular Profile (CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of the Intestinal Microbiota for Treatment Efficiency, Toxicity, Survival and Quality of Life in Patients With Metastatic or Unresectable Colorectal Cancer During Irinotecan-based Systemic Treatment
Colorectal Neoplasms
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology